We are pleased to announce that we have issued new shares to Aioi Nissay Dowa Insurance Co. through third party allocation.
Both companies are looking to work on further raising the awareness of N-NOSE, enhancing the after-sales services, and on developing insurance products.
The international biomedical journal Biomedicines has just published a peer-reviewed review article* on data showing the effectiveness of N-NOSE . . .
2024.11.15At the Excellence in Oncology Care (EIOC) 2024 conference held in Dubai from October 11 (Fri.) to 13 (Sun.), 2024, our Shonan R&D Center Res . . .
2024.10.25We, HIROTSU BIO SCIENCE Inc., participated in the Excellence in Oncology Care (EIOC) 2024 conference that was held in Dubai from October 11th (F . . .
2024.10.17